EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective
Abstract
Authors
K Guinan K Mathurin Y Au AC Schuh CN Bui X Chai J Lachaine